Noom is teaming-up with the Icahn School of Medicine at Mount Sinai hospital in New York and Kaiser Permanente over a 12-week, 200-person trial of a new mobile health app for eating disorders called Noom Monitor.
Back in October 2013, the company picked up an NIH grant to develop and test Noom Monitor with 80 participants, That trial was completed in May 2015, according to a ClinicalTrials.gov post, but results are yet to be published. Apparently it was successful enough to warrant a follow-up.
The Noom Monitor app bares resemblance to the existing Noom app, which helps users track their eating habits for weight management purposes. It, however, adds check-ins that are designed to emulate the principles of cognitive behavioral therapy and guided self-help (CBT-GSH), which are typical interventions for eating disorders; also, there’s an interface for therapists to check in on users’ food logs.
The Noom Monitor app adds check-ins on top of the regular Noom app to emulate the principles of cognitive behavioral therapy and guided self-help.The app will be tested by a large population of eating disorder patients in the Kaiser Permanente healthcare system. A control group will use any care options currently available to KP patients with eating disorders. Researchers will check in with patients at four, eight, and 12 weeks and then again for three, six, and 12-month follow-ups. They will assess frequency of binge episodes, shape and weight concerns, global eating pathology in the group that used the app and the group that didn’t.
If the study goes well, Noom Monitor will be released as a commercial product, while helping the company “establish a database of training materials.”
Beyond dealing with weight loss issues, Noom is also tackling several chronic conditions. In January of this year, the company secured $16 million in funding, and has entered a licensing deal with Rodale. To date, Noom has raised more than $25 million total to date.